Please assess the completion status of the following clinical trial:

Trial Title: Sex and Obesity: Effects on Heart Failure Study

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: OTHER
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion criteria~* Heart failure (HF) and a systolic ejection fraction \<45% per a recent echocardiogram report)~* Nonischemic HF New York Heart Association Class II-III~* Ambulatory~* Able to give informed consent~* On a stable medical regimen including the standard-of-care HF medications (i.e., a beta-blocker, ACE-inhibitor or angiotensin receptor blocker \[ARB\])~Exclusion criteria~* Participants who were pregnant or lactating~* Actively losing weight~* Nonsedentary (performing aerobic exercise \> 30 minutes x 3 times/week)~* Those who have more than Class I hypertension~* Those who require alterations in beta-blocker or ACE or ARB-inhibition medication~* Those with hypertrophic, constrictive, or restrictive cardiomyopathies~* Those unable to lie flat in the PET scanner~* Severe major organ system dysfunction (other than heart failure)~* Significant coronary artery disease by catheterization~* Those unable to give informed consent

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Men with heart failure (Type: None): Men with obesity-related heart failure
- Women with heart failure (Type: None): Women with obesity-related heart failure

Based on this trial design, predict the completion outcome and termination type (if applicable).